No results for ‘’
Bliss GVS Pharma Ltd
₹694.60
(5.00%)
Mon, 28 Sept 2026, 02:01 am
Bliss GVS Pharma Share Price Live Chart
1 Day
(5.00%)
No Result Found
Summary
Market Cap (in Cr)
4493.92
Net Profit (in Cr)
90.26
P/B
1.18
Sector P/E
33.76
P/E
14.69
EV/EBITDA
6.82
Debt/Equity (Industry)
0.26
Interest Cover (Industry)
10.81
ROCE (Industry)
16.40
RONW (Industry)
14.39
ROE
8.95
ROCE
12.09
Debt/Equity
0.09
EPS (TTM)
12.36
Dividend Yield
0.24
Book Value
112.76
Interest Cover
16.47
Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 35.36 | 35.36 | 35.39 | 35.44 | 35.29 |
| FII | 10.45 | 14.54 | 13.27 | 12.65 | 13.18 |
| DII | 5.04 | 5.78 | 5.98 | 6.54 | 6.55 |
| Public | 49.15 | 44.32 | 45.36 | 45.36 | 44.98 |
| Government | 0 | 0 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 875.50 | 720.55 | 668.65 | 565.60 | 513.70 | 410.65 | 255.70 |
| Fibonacci | 720.55 | 661.36 | 624.79 | 565.60 | 506.41 | 469.84 | 410.65 |
| Camarilla | 659.36 | 645.16 | 630.95 | 565.60 | 602.55 | 588.34 | 574.14 |
Pivots Level: Classic
R3
+309.90
875.50
R2
+154.95
720.55
R1
+103.05
668.65
S1
-51.90
513.70
S2
-154.95
410.65
S3
-309.90
255.70
Moving Average
Period
Value
10-EMA
687.59
20-EMA
664.66
30-EMA
639.29
50-EMA
595.13
100-EMA
509.52
200-EMA
402.86
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 12 May 2026 | agm | ||
| 12 May 2026 | board-meetings | Accounts, Final Dividend | |
| 10 Feb 2026 | dividend | ₹0.50 Dividend /Share | 18 Feb 2026 |
| 10 Feb 2026 | board-meetings | Quarterly Results, Interim Dividend | |
| 18 Jan 2026 | dividend | Interim Dividend - Re 0.50 Per Share | 18 Feb 2026 |
| 06 Nov 2025 | board-meetings | Quarterly Results | |
| 24 Jun 2025 | dividend | Final Dividend - Rs. - 0.5 | 24 Jul 2025 |
| 12 May 2025 | agm | ||
| 12 May 2025 | dividend | ₹0.50 Dividend /Share | 24 Jul 2025 |
| 18 Jun 2024 | dividend | Annual General Meeting/Dividend - Rs 0.50 Per Share | 19 Jul 2024 |
Peer Comparison
Bliss GVS Pharma Ltd
Dr Reddys Laboratories Ltd
Torrent Pharmaceuticals Ltd
Divis Laboratories Ltd
Sun Pharmaceutical Industries Ltd
Cipla Ltd
Bliss GVS Pharma Ltd About
Bliss GVS Pharma is engaged in manufacturing, marketing, trading and export of pharmaceutical products. The Company is one of among the world leaders in Suppositories and Pessaries dosage forms with one of the largest portfolios in this segment.
Industry
Pharmaceuticals - Indian - Formulations
Founded
1984
Headquarters
CEO
Nandkumar Kashinath Chodankar
Employees
Contact
Website
http://www.blissgvs.com
cs@blissgvs.com; info@blissgvs.com
Phone
91-22-42160000
Location
102 Hyde Park Sakivihar Road, Andheri East, Mumbai, Maharashtra, 400072
Bliss GVS Pharma Ltd Company History
| Year | History |
|---|---|
| 2012 |
|
| 2013 |
|
| 2014 |
|
| 2015 |
|
| 2016 |
|
Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| HRTI PRIVATE LIMITED | bulk | Sell | 562933 | 420.49 | 29 May 2026 |
| HRTI PRIVATE LIMITED | bulk | Buy | 457998 | 419.26 | 29 May 2026 |
| SHAILESH SHIVKUMAR DALMIA | bulk | Sell | 1008910 | 317.64 | 25 May 2026 |
| HRTI PRIVATE LIMITED | bulk | Sell | 581292 | 224.86 | 25 Mar 2026 |
| HRTI PRIVATE LIMITED | bulk | Buy | 517506 | 224.26 | 25 Mar 2026 |
| RATNABALI EQUITY PRIVATE LIMITED | bulk | Sell | 717102 | 212.11 | 20 Mar 2026 |
| RATNABALI EQUITY PRIVATE LIMITED | bulk | Buy | 717000 | 212.56 | 20 Mar 2026 |
| MATEUS LTD | bulk | Buy | 933978 | 210.81 | 19 Mar 2026 |
| ARIAN INVESTMENT LTD | bulk | Sell | 1000000 | 210.82 | 19 Mar 2026 |
| MANSUKH SECURITIES & FINANCE LIMITED | bulk | Sell | 620900 | 216.22 | 24 Feb 2026 |
Frequently Asked Questions
1.What is the stock price of Bliss GVS Pharma Ltd?
As of 28/09/2026 at 7:31 AM, Bliss GVS Pharma Ltd shares are trading at ₹694.60.
2.What is the market cap. of Bliss GVS Pharma Ltd?
As of 28/09/2026, the market capitalization of Bliss GVS Pharma Ltd is ₹6,988.13 crore.
3.When was Bliss GVS Pharma Ltd founded?
Bliss GVS Pharma Ltd was founded in 1984.
4.What are the P/E and P/B ratios of Bliss GVS Pharma Ltd?
As of 28/09/2026, Bliss GVS Pharma Ltd has a P/E ratio of 55.08 and a P/B ratio of 1.18.
5.How can I buy shares of Bliss GVS Pharma Ltd?
You can buy shares of Bliss GVS Pharma Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.
6.What is the shareholding pattern of Bliss GVS Pharma Ltd?
As of March,2026, promoters hold 35.36% in Bliss GVS Pharma Ltd, while FIIs, DIIs and public shareholders hold 10.45%, 5.04% and 49.15%, respectively.
7.Does Bliss GVS Pharma Ltd pay dividends?
Yes, Bliss GVS Pharma Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹₹0.50 Dividend /Share per share.
8.What is the dividend yield of Bliss GVS Pharma Ltd?
As of 28 September, 2026, the dividend yield of Bliss GVS Pharma Ltd stands at 0.22%.
9.What are the latest financial results of Bliss GVS Pharma Ltd?
For January,2024, Bliss GVS Pharma Ltd reported revenue of ₹802.00 crore and a net profit of ₹84.30 crore.
10.What is the Stock symbol of Bliss GVS Pharma Ltd?
BLISSGVS is the stock symbol of Bliss GVS Pharma Ltd.
11.Who is the CEO of Bliss GVS Pharma Ltd?
The CEO of Bliss GVS Pharma Ltd is Nandkumar Kashinath Chodankar.